REQUEST A DEMO
Total
USD $0.00
Search more companies

I Pharma Company Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: I Pharma Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

I Pharma Company Limited is an enterprise in Thailand, with the main office in Bangkok , Special Governed District of. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on June 01, 2026. I Pharma Company Limited currently employs 1 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 36.62% in 2024. During that time, I Pharma Company Limited’s total assets grew by 11.17%. The net profit margin of I Pharma Company Limited increased by 2.85% in 2024.

Headquarters
641/80-81 Anamai Ngam Charoen Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10150

Contact Details: Purchase the I Pharma Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the I Pharma Company Limited report to view the information.
Financial Auditors:
Purchase the I Pharma Company Limited report to view the information.
Incorporation Date:
June 01, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after I Pharma Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
36.62%
Total Operating Revenue
36.85%
Operating Profit
92.24%
EBITDA
92.24%
Net Profit/Loss for the Period
243.33%
Total Assets
11.17%
Total Equity
24.82%
Operating Profit Margin
2.42%
Net Profit Margin
2.85%
Return on Equity (ROE)
16.82%
Debt / Equity
-53.22%
Quick Ratio
0.4%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?